Abstract
53 Oral First results of the phase II EORTC trial 20962 evaluating high-dose MTX-based chemotherapy followed by consolidating radiotherapy in non-AIDS related primary central nervous system lymphoma (NAPCL)
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
